THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,223,000 | +1.2% | 38,390 | +15.3% | 0.00% | 0.0% |
| Q3 2016 | $1,208,000 | +68.2% | 33,306 | +5.3% | 0.00% | – |
| Q2 2016 | $718,000 | +20.1% | 31,641 | -0.5% | 0.00% | – |
| Q1 2016 | $598,000 | +29.2% | 31,801 | +12.8% | 0.00% | – |
| Q4 2015 | $463,000 | +47.9% | 28,197 | -0.7% | 0.00% | – |
| Q3 2015 | $313,000 | -11.8% | 28,410 | +4.0% | 0.00% | – |
| Q2 2015 | $355,000 | -21.3% | 27,310 | +5.1% | 0.00% | – |
| Q1 2015 | $451,000 | +20.6% | 25,985 | +3.7% | 0.00% | – |
| Q4 2014 | $374,000 | +30.3% | 25,055 | +100.9% | 0.00% | – |
| Q3 2014 | $287,000 | -5.0% | 12,473 | +31.5% | 0.00% | – |
| Q2 2014 | $302,000 | – | 9,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |